Skip to content

REACH Orphan Substances Consortium

Active Risk: Private limited companyfounded 2015active for 11 yearsHaverstraat 8, 2350 VosselaarKBO/BCE: BE 0630.838.609

Lifetime

10 annual accounts with figures on one time axis
peak of €3,577 in 2021
-€6,176▼ €4,315
-not published
peak of €6,200 in 2016
€6,200unchanged
€1.2m▲ 18.9%
Board1 name since 2015
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from -€1,861 to -€6,176Debts from €996,247 to €1.2mCash from €120,623 to €253,465

Key points

from the 2025 annual accounts

Debts

€1.2m 99% of the balance sheet

Filings

10 annual accounts 1 late
AprilJune31 JulyOctober20202025

The 2020 accounts came 15 days late. The other nine were filed on time.

Position in the sector

0.5%

Lower solvency than 85% of companies in other professional activities. Sector median 42.8% · 732 companies.

Turnover not published in the abbreviated format

Bankruptcy probability

No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Bankruptcy probability within 12 months
Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 04-06-2015
  • founderdeed of 04-06-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0630838609
changes role from manager to director General meeting of 02-03-2021 · Gazette deed
Registered office moved from Beerse to Vosselaar The registered office moved from Peggersstraat 25, 2340 Beerse to Haverstraat 8, 2350 Vosselaar · Board meeting of 28-02-2018 · Gazette deed
First establishment At the time the registered office was still in Beerse, Peggersstraat 25.
All 15 events

Comparable companies

same main activity, similar in size and age
Company
REACH Orphan Substances Consortium Vosselaar €1.2m -€6,176 0.5% -
ZORGLANDSCHAP Antwerp €1.0m -€1,128 11.6% 0
Virtual Physiological Human Institute for Integrative Biomedical Research Leuven €1.2m -€124,194 8.2% -
ZAPPASS Herenthout €2.0m -€85,326 26.5% -
Ecorus BE Diest €1.5m -€144,091 -22.9% -
CATALYA Liège €1.2m -€22,818 86.4% -
European Calcified Tissue Society Ixelles €0.9m -€65,060 92.0% -

These companies have the same main activity as REACH Orphan Substances Consortium: other professional, scientific and technical activities (NACE 74999). They are comparable in size and age: total assets between €879,000 and €2m, founded between 2010 and 2019.

Official details

Source: KBO
Status
Active since 21-05-2015Normal situation
Activity
Other professional, scientific and technical activitiesNACE 74999and 1 other
Establishment unit
2.242.797.5742350 Vosselaar, registered on 25-05-2015
Financial year end
31 December
Peppol
Reachable since 12-11-2025
Company details

Annual accounts 2025

€1.2m▲ 18.8%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on REACH Orphan Substances Consortium

REACH Orphan Substances Consortium files the abbreviated format. That format states no turnover. The gross margin fell from €8 in 2016 to -€6,176 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about REACH Orphan Substances Consortium

What is the company number of REACH Orphan Substances Consortium?
The company number of REACH Orphan Substances Consortium is 0630.838.609. The VAT number is the same number with BE in front: BE 0630.838.609.
Where is REACH Orphan Substances Consortium based?
The registered office is at Haverstraat 8, 2350 Vosselaar.Company details
What does REACH Orphan Substances Consortium do?
According to the KBO register, the main activity is other professional, scientific and technical activities (NACE 74999).
What is the legal form of REACH Orphan Substances Consortium?
REACH Orphan Substances Consortium is a private limited company (BV).
When was REACH Orphan Substances Consortium founded?
REACH Orphan Substances Consortium was founded on 21-05-2015.
Is REACH Orphan Substances Consortium still active?
Yes, REACH Orphan Substances Consortium is an active enterprise in the KBO register.
What is the turnover of REACH Orphan Substances Consortium?
The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it. In financial year 2020 turnover was €758,883.Financials
Where can I find the annual accounts of REACH Orphan Substances Consortium?
REACH Orphan Substances Consortium filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of REACH Orphan Substances Consortium due?
REACH Orphan Substances Consortium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.